Somaxon Pharmaceuticals, Inc.·4

Sep 24, 7:06 PM ET

Cobb Terrell 4

4 · Somaxon Pharmaceuticals, Inc. · Filed Sep 24, 2010

Insider Transaction Report

Form 4
Period: 2010-09-22
Cobb Terrell
Director
Transactions
  • Sale

    Common Stock

    2010-09-22$4.24/sh11,282$47,80049,265 total
Footnotes (3)
  • [F1]This sale was effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.18 to $4.34, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  • [F3]These shares represent restricted stock units that are unvested.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION